BACKGROUND: Complete fertilization failure after ICSI is a rare event, and it may happen repeatedly even in cases of normal sperm parameters and good ovarian response. In these cycles, alternative ICSI techniques may prove useful. METHODS: Our modified ICSI (mICSI) is characterized by aspiration close to the opposite membrane (the region of the mitochondria with a high inner mitochondrial membrane potential) which is followed by central deposition of the sperm. The method was applied prospectively to ICSI cycles of patients with a history of complete fertilization failure in previous ICSI cycles. In parallel, mICSI was compared with conventional ICSI in terms of further preimplantation development and treatment outcome. RESULTS: In patients with previous ICSI failures using conventional ICSI (no 2Pn zygotes out of 70 oocytes that had been injected) application of mICSI led to adequate fertilization (53.6%) and pregnancy rates (33.3%) (P < 0.001; P < 0.01). In patients without previous failed fertilization, no improvement in the rates of fertilization, blastocyst formation, implantation or clinical pregnancy could be seen. CONCLUSIONS: Our data indicate that the present version of ICSI is a reliable alternative to conventional ICSI. However, although it overcomes oocyte-dependent activation failure, routine application does not improve the overall results.
Introduction
Since the first reported success with ICSI in humans (Palermo et al., 1992) , this method has become the preferred treatment option for severe male factor infertility using ejaculated, epididymal or testicular spermatozoa. Regardless of this wide variety of potential sperm sources, the injection procedure itself has remained unchanged throughout the years.
Two steps are considered essential for successful fertilization, namely immobilization of the spermatozoon and rupture of the oolemma (Svalander et al., 1995; Van den Bergh et al., 1995; Vanderzwalmen et al., 1996) . The mechanism of human oocyte activation during ICSI is not exactly known (Edwards and Van Steirteghem, 1993) . However, a sperm-associated factor is likely to be responsible for initiation of egg activation in ICSI (Dozortsev et al., 1995 (Dozortsev et al., , 1997 Parrington et al., 1996) apart from a parthenogenetic effect caused by the injection procedure per se (Winston et al., 1991; De Sutter et al., 1992) . In addition, a certain oocyte -sperm interaction, e.g. ooplasmic factors triggering sperm chromatin decondensation (Tesarik and Kopecny, 1989; Van Blerkom et al., 1994; Dozortsev et al., 1997) , is required.
The complexity of the fertilization process may explain its susceptibility to disturbances which may cause complete fertilization failure in spite of the presence of a presumably normal spermatozoon (Sousa and Tesarik, 1994; Dozortsev et al., 1995; Ludwig et al., 1999) . The frequency of total fertilization failure cycles was reported to be , 1 -3% (Liu et al., 1995; Moomjy et al., 1998; Ludwig et al., 1999) , most of them being the result of impaired semen characteristics or very low oocyte numbers. In such cases, repeated ICSI treatment proved useful (Liu et al., 1995; Moomjy et al., 1998) ; however, some patients will have to face repeated fertilization failure in spite of normal sperm parameters and good ovarian response (Moomjy et al., 1998; Tesarik et al., 2002) .
In order to rescue such cycles, Tesarik et al. (2002) reported a modified ICSI technique mainly based on a repeated dislocation of the central ooplasm to the periphery, thus increasing the intracellular concentration of free calcium either by creating an influx of calcium ions (Tesarik and Sousa, 1995) or by the release of calcium stored in cell organelles.
Taking into account a possible negative effect of this rather vigorous injection technique on further preimplantation development (Dumoulin et al., 2001; Eichenlaub-Ritter et al., 2002) , we developed a modified ICSI (mICSI), which is based on the hypothetical accumulation of highly polarized mitochondria, e.g. showing a high inner mitochondrial membrane potential (Van Blerkom et al., 2002) , from pericortical regions (9 o'clock) to the centre of the oocyte, thus, theoretically, supplying more energy (ATP) directly to the place where the spermatozoon was injected. In this regard, it appeared that aggregation patterns of mitochondria correspond well to the light microscopic appearance of the oocyte .
Encouraged by promising preliminary results, we prospectively applied this mICSI approach to patients with previous fertilization failure after ICSI. In parallel, a possible application as a routine method has been evaluated comparing conventional ICSI with the modified technique in sibling oocytes. Once the equivalence of both methods in terms of fertilization and preimplantation development had been established, a randomized prospective study of patients was set up to evaluate the actual influence of mICSI on pregnancy and implantation behaviour.
Material and methods
This study was approved by the institutional review board, and all patients provided written informed consent for their participation.
In the first phase of the study, 14 patients (32.2^4.4 years) having had no fertilization with conventional ICSI in 17 previous cycles were treated with a modified injection technique. Total fertilization failure was not due to low response (. 3 oocytes) or severe male factor infertility (. 5 £ 10 6 /ml). In the second phase, ICSI was applied on sibling oocytes of 24 consecutive patients (33.0^4.6 years) who showed a good response to controlled ovarian stimulation. Approximately half of the metaphase II (MII) oocytes of each patient were injected using conventional ICSI and half of the gametes using the new technique.
In the last phase, 92 ICSI cycles were allocated alternatively to the conventional ICSI group or the mICSI group. All ICSI patients met our inclusion criteria, which were female age , 40 years, additional tubal or unexplained infertility and fewer than four previous stimulated cycles.
All 127 patients presented at our clinic in 2003 and were stimulated with either a long protocol (n ¼ 55) using buserelin (Suprecur w ; Aventis Pharma, Vienna, Austria) and HMG (Menogon w ; Ferring, Kiel, Germany) or an antagonist protocol (n ¼ 72) with administration of recombinant FSH (Puregon w ; Organon, Vienna, Austria) and GnRH antagonist (Orgalutran w ; Organon, Vienna, Austria). In all patients, ovulation was induced with 5000 -10 000 IU of HCG (Pregnyl w ; Organon, Vienna, Austria) provided that lead follicles and serum estradiol appeared adequate. Oocyte retrieval was carried out transvaginally under ultrasound guidance 36 h after ovulation induction.
After careful denudation of the oocytes and identification of the mature oocytes, conventional ICSI was performed as previously described (Ebner et al., 2001) . In detail, the first polar body was kept at the 6 o'clock position while the injection needle passed the zona pellucida and the oolemma at the 3 o'clock position. Once the centre of the oocyte was reached, aspiration of a small amount of ooplasm was done followed by central deposition of the mechanically immobilized spermatozoon.
Since the mICSI aimed to accumulate peripheral mitochondria of high inner mitochondrial membrane potential to the region of pronuclear formation, the needle tip was pushed close to the membrane opposite the puncture site (9 o'clock position) where careful aspiration of cytoplasm was performed ( Figure 1 ). The peripheral region bearing mitochondria with a high inner mitochondrial membrane potential could be located easily since aggregation patterns of mitochondria corresponded well to the light microscopic appearance of the oocyte . The degree of aspiration was comparable with conventional ICSI. If a certain response of the opposite membrane was noted during aspiration, e.g. a slight invagination (Figure 2 ), the aspiration process was stopped immediately and the sperm was released in the centre of the female gamete. Special care was taken to avoid lateral deviations from the original injection channel.
On day 1 (16 -18 h after injection), fertilization was assessed and only zygotes presenting two pronuclei and two polar bodies were considered as normal. The pronuclear pattern was scored as suggested elsewhere (Tesarik and Greco, 1999) . At the zygote stage, the medium was changed from BM1 medium (NMS Bio-Medical, Praroman, Switzerland) to Blastassist System Medium 1 (MediCult, Copenhagen, Denmark).
On day 2, embryos were checked for the number and size of blastomeres as well as for the percentage of fragmentation. Culture (10 ml per embryo) was prolonged in Blastassist System Medium 2 (MediCult) until day 3 or 5. If day 5 transfer was considered, the extension and quality of blastocysts were checked according to our routine method (Ebner et al., 2003) . It has to be kept in mind that the number of blastocysts checked for quality differs from the total number of blastocysts since some early blastocysts did not show a clearly distinguishable inner cell mass and trophectoderm.
Summarizing all three phases of the present study, transfer was done on either one day 3 (n ¼ 73) or day 5 (n ¼ 54), using a small volume of Blastassist System Medium 2 in an Edwards -Wallace Catheter (Smiths Industries, Lancing, UK). To support the luteal phase, 3000 IU of HCG (Pregnyl w ; Organon, Vienna, Austria) were injected on day 2, day 5 and day 8. The clinical pregnancy rate and implantation rate were calculated using pooled day 3 and day 5 results. The ratio of day 3/day 5 transfers did not vary in both cohorts. Nineteen days after oocyte collection, the blood concentration of bHCG was measured to exclude biochemical pregnancies (, 20 mU/ml). Clinical pregnancy was defined by transvaginal ultrasound visualization of a gestational sac with positive heart activity 4 weeks after embryo transfer. Subclinical pregnancy revealed no fetal heartbeat. The implantation rate was determined by ultrasound visualization of a gestational sac per transferred embryo (subclinical pregnancies were included).
Comparison between the two ICSI cohorts was performed using x 2 and Mann -Whitney U hypothesis tests. Statistical significance was defined as P , 0.05.
Results
In 14 patients (17 cycles) characterized by oocyte activation failure, not a single 2PN zygote could be achieved out of 70 oocytes using conventional ICSI. However, following 15 cycles of mICSI, an overall fertilization rate of 53.6% (45 out of 84) (P , 0.001) was observed. This time all patients had an embryo transfer, which resulted in an implantation rate of 16.1% (five out of 31) and a clinical pregnancy rate of 33.3% (P , 0.05).
During the second phase of our study which dealt with sibling oocytes (n ¼ 277), an overall fertilization rate of 74% (205 out of 277) was seen, 67 (32.7%) of the zygotes showing optimal pronuclear patterns 0. After first cleavages had occurred, 25.4% (52 out of 205) of all embryos were found to have no signs of fragmentation. Overall, 179 cleaved embryos were considered for blastocyst culture, but only 99 (55.3%) reached this stage on day 5. Approximately half (31 out of 70) of the blastocysts showed an inner cell mass of optimal morphology. Table I indicates that both methods, i.e. conventional ICSI and mICSI, trying to concentrate peripheral mitochondria in the centre of the oocyte, are comparable in outcome (P . 0.05).
As indicated in Table II , both patient collectives of study phase 3 (prospective comparison of transfers of both ICSI techniques) did not differ in primary parameters, such as age, history of infertility or response to ovarian stimulation. In addition, the number and quality of concepti transferred were identical in both groups (P . 0.05). During this third phase of the study, bHCG was positive in 35 out of 92 cases (38%). Since three biochemical pregnancies and three subclinical pregnancies occurred, the implantation rate was found to be 21% (38 out of 181) and the clinical pregnancy rate 31.5% (19 out of 92). Table II clearly supports the hypothesis that both ICSI versions did not differ in treatment outcome.
Discussion
Mitochondria are maternally inherited organelles that are functionally heterogeneous and non-randomly dispersed within the oocyte and undergo stage-dependent intracellular translocation. In detail, a microtubule-generated withdrawal of mitochondria to the perinuclear region takes place at pronuclear formation, leaving a characteristic halo-like area of cytoplasmic translucency close to the oolemma. Hypothetically, this microtubule-dependent mitochondrial clustering serves to supply energy directly to the pronuclei, considering that simple diffusion of ATP across the ooplasm would be too time-consuming due to the large oocyte diameter. In addition, mitochondria may play a role in protection against oxygen radicals by reducing the oxygen concentration around the pronuclei (Bavister and Squirrell, 2000) .
In order to evaluate a possible correlation between the respiratory activity of mitochondria in oocytes and the corresponding preimplantation development, two main approaches have been considered: (i) assessment of intracellular ATP content (Van Blerkom et al., 1995 ; and (ii) indirect assessment of mitochondrial activity measuring the inner mitochondrial membrane potential (Wilding et al., , 2002 Van Blerkom et al., 2002 . Values in parentheses are percentages. No statistically significant differences could be observed. For quality assessment, only full blastocysts and early blastocysts with a clearly distinct inner cell mass and trophectoderm were evaluated; P . 0.05.
Modified injection technique overcomes complete activation failure after ICSI
Wilding et al. (2001) described two different mitochondrial aggregation patterns in MII oocytes, one granular aggregation pattern restricted to the periphery (type A), and a smoother pattern found towards the centre of the gamete (type B). Interestingly, both patterns were characterized by similar inner mitochondrial membrane potentials.
On the other hand, Van Blerkom et al. (2002) found mitochondria in oocytes to be heterogeneous with respect to the inner mitochondrial membrane potential and described those organelles considered to be highly polarized, and thus being of high metabolic ATP activity, to be located along the pericortical region. These mitochondria may maintain adequate ATP levels in the subplasmalemmal zone while other mitochondria move to the centre of the ooplasm during the fertilization process (Van Blerkom et al., 2003) and/or play a key role in Ca 2 þ regulation at oocyte activation (Ozil and Huneau, 2001 ).
The reported clustering of highly polarized mitochondria in subplasmalemmal regions led us to try an accumulation of such peripheral organelles close to the spermatozoon during injection in cases of complete fertilization failure after ICSI. MII oocytes from such patients are thought to have a significantly lower mitochondrial DNA copy number compared with gametes with a normal rate of fertilization (Reynier et al., 2001) . This metabolic dilemma is possibly the result of cytoplasmic maturational incompetence (Barritt et al., 2002) . Theoretically, during maturation, transition from the more peripheral mitochondrial aggregation type A , which is found in primary oocytes (Sathananthan and Trounson, 2000) and fresh (time from ovulation induction) MII oocytes , to the more equal distribution of mitochondria in aggregation type B cannot occur. This would lead to the dilemma that an insufficient number of mitochondria is present in the centre of the gamete.
Another hypothesis would be that minor disturbances in the cytoskeleton at maturation may indirectly affect mitochondrial clustering, which could result in mitochondrial 'microdomains' of impaired function (Eichenlaub-Ritter et al., 2004) .
Provided that oocytes from patients with complete fertilization failure after ICSI produce such affected oocytes in subsequent cycles, mICSI would ensure not only the presence of a higher number of mitochondria at the site of pronuclear formation but also the presence of mitochondria of high metabolic ATP activity, both of which are thought to promote fertilization and preimplantation development Barritt et al., 2002) .
However, it has to be clearly stated that this work does not offer evidence that peripheral mitochondria are actually removed to the centre at all. Nevertheless, considering previous data (Van Blerkom et al., 1998) , it is quite within the bounds of probability. Specifically, the feasibility of mitochondrial transfer between two oocytes could be demonstrated; furthermore, the persistence of activity in the transferred organelles (e.g. ATP production) was found to be maintained. Maintainance of the biological function of the removed mitochondria is strongly supported by several pregnancies which were achieved after cytoplasmic transfer (Cohen et al., 1998; Dale et al., 2001) . Consequently, if dislocation of mitochondria works at a distance, it seems highly likely that it will also work within an oocyte. The final proof of the presence of active mitochondria around the spermatozoon would require a separate study, which is, unfortunately, not possible in Austria due to the restictive legislation in place.
In addition to the presumed increase in ATP supply, this new injection technique is likely to enrich intracellular free calcium ions compared with standard ICSI. Similar to the injection technique of Tesarik et al. (2002) , the manipulation (e.g. aspiration of the ooplasm, repeated movement of the pipette) during our mICSI will cause an influx of calcium from the surrounding medium (Tesarik and Sousa, 1995) . In addition, calcium stored in the endoplasmic reticulum will be set free due to mechanical damage of this organelle. Enhancement of intracellular calcium ions will positively affect trigger components of calcium-dependent oocyte activation, theoretically alleviating any impairment of the oscillatory component (Tesarik et al., 2002) .
However, it must be emphasized that the positive effect of our mICSI that could be shown in cases of previous fertilization failure after standard ICSI could not be demonstrated in T. Ebner et al. cases without this problem since the fertilization rate and further development were comparable. This implies that a minimum baseline of functionally active mitochondria must have been present in oocytes without impaired fertilizability, as suggested by Barritt et al. (2002) . One additional reason would be the patient selection criteria applied for the second and third part of the study with the female range not exceeding an age of 40 years, since it is well documented that mitochondrial activity is negatively correlated to maternal age ). To conclude, mICSI which possibly accumulates mitochondria with a higher inner mitochondrial membrane potential proved to be a reliable and safe alternative to conventional ICSI as could be shown by comparable rates of blastocyst formation, implantation and clinical pregnancy. In particular, the present technology proved useful in terms of previous failure of fertilization in ICSI patients.
